Neurological Disorder Drugs Market to Expand Notably, Foresees Fairfield Market Research London, March 06, 2023 (GLOBE NEWSWIRE) -- Neurological disorders have been among the leading causes of mortality worldwide. Although a majority of neurological conditions predominantly tends to...

AI in Drug Discovery Market to Rise at 36.1% CAGR during Forecast Period: TMR Study Wilmington, Delaware, United States, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – By 2031, the AI in drug discovery market size is estimated to surpass value of US$ 10.93...

Neurological Disorder Drugs Market to Reach Tremendous Value of US$ 125.60 Billion during Forecast 2022-2029, Size, Share, Industry Growth, Competitive Analysis and Trends forecast NEW YORK, Sept. 19, 2022 (GLOBE NEWSWIRE) -- A Qualitative Research Study accomplished by Data Bridge Market research's database of 350 pages, titled as “Global Neurological Disorder Drugs Market”...

Neurological Disorder Drugs Market to Expand with Rise in Focus of Players on Development of 3D CNS Organoids, States TMR Study Increase in number of patients suffering from disorders, such as multiple sclerosis, Parkinson’s disease, cerebrovascular diseases, Alzheimer’s disease, and epilepsy is bolstering the market ALBANY,...

Neurological Disorder Drugs Market Report Up to 2031: Visiongain Research Inc Visiongain has published a new report on Neurological Disorder Drugs Market Report 2021-2031: Forecasts By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic,...